DermaWash S2

Manufacturer
KAVI Skin Solutions, Inc.
Effective date
2020-10-20
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-05-31 23:32:03

Label at a glance#

ProductDermaWash S2
Active ingredientSULFUR
Label structure8 sections

Label contents#

Full prescribing information#

Dosage & Administration

DOSAGE & ADMINISTRATION SECTION

Directions for Use:
1. Rinse face and/or body with warm water.
2. Dispense 1 to 2 pumps of cleanser onto palm or washcloth.
3. Rub palms or washcloth together, spreading cleanser evenly and building a lather.
4. Cleanse skin gently but thoroughly.
5. Rinse face and/or body with warm water.

Purpose

OTC - PURPOSE SECTION

Designed for daily use, KAVI DermaWash S2 provides an ideal approach to cleansing oily or combination skin. DermaWash S2 utilizes allergy-tested ingredients that are non-comedogenic, pH-balancing, and completely free of animal products.

With the same dosage of sulfur as Coral KAVI, DermaWash S2 is best suited for the treatment of acne-prone skin.
DermaWash S2 can be also used in preparation of the skin prior to administration of a KAVI chemical peel.

Indications & Usage

INDICATIONS & USAGE SECTION

DermaWash S2 is best suited for the treatment of acne-prone skin.

Directions:
1. Rinse face and/or body with warm water.
2. Dispense 1 to 2 pumps of cleanser onto palm or washcloth.
3. Rub palms or washcloth together, spreading cleanser evenly and building a lather.
4. Cleanse skin gently but thoroughly.
5. Rinse face and/or body with warm water.

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: colloidal sulfur (2%)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Inactive Ingredients: purified water, lauric acid, acrylates copolymer, cocamidopropyl betaine, potassium hydroxide, myristic acid, glycerin, ethylene glycol distearate, olive oil PEG-7 ester, hamamelis virginiana extract, polyquaternium-7, sodium laureth sulfate, DMDM tocopherol acetate, butyl hydroxy toluene, disodium EDTA, light fragrance.

Warnings

WARNINGS SECTION

For external use only. If swallowed, seek medical attention. Avoid contact with eyes and mucous membranes. In case of eye contact, flush with cold water. Keep out of reach of children.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

CAUTION: For external use only. If swallowed, seek medical attention. Avoid contact with eyes and mucous membranes. In case of eye contact, flush with cold water. Keep out of reach of children.

Front and Back Labels

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label front and backlabel front and back

Designed for daily use, KAVI DermaWash S2 provides an ideal approach to cleansing oily or combination skin. DermaWash S2 utilizes allergy-tested ingredients that are non-comedogenic, pH-balancing, and completely free of animal products.
With the same dosage of sulfur as Coral KAVI, DermaWash S2 is best suited for the treatment of acne-prone skin.
DermaWash S2 can be also used in preparation of the skin prior to administration of a KAVI chemical peel.

DermaWash S2 is made with colloidal sulfur to enhance the hydrolipidic layer’s acidity and protect skin from bacterial infections. Suitable for use on the face and body, it is easy on the senses and a practical replacement to traditional animal-based soaps.

Directions:
1. Rinse face and/or body with warm water.
2. Dispense 1 to 2 pumps of cleanser onto palm or washcloth.
3. Rub palms or washcloth together, spreading cleanser evenly and building a lather.
4. Cleanse skin gently but thoroughly.
5. Rinse face and/or body with warm water.

Active Ingredient: colloidal sulfur (2%). Inactive Ingredients: purified water, lauric acid, acrylates copolymer, cocamidopropyl betaine, potassium hydroxide, myristic acid, glycerin, ethylene glycol distearate, olive oil PEG-7 ester, hamamelis virginiana extract, polyquaternium-7, sodium laureth sulfate, DMDM tocopherol acetate, butyl hydroxy toluene, disodium EDTA, light fragrance.

CAUTION: For external use only. If swallowed, seek medical attention. Avoid contact with eyes and mucous membranes. In case of eye contact, flush with cold water. Keep out of reach of children.

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1928004sulfur 2 % Medicated Liquid SoapPSN4
1928004sulfur 20 MG/ML Medicated Liquid SoapSCD4
1928004sulfur 2 % Medicated Liquid SoapSY4

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
42771-0036-12023-01-30C16284748780-19d75b9d0-8bf9-f424-e053-dadaa90a57ceDermaWash S2
42771-0036-12020-02-28C16284748780-19d75b9d0-8bf9-f424-e053-dadaa90a57ceDermaWash S2
42771-0036-12020-01-31C16284748780-19d75b9d0-8bf9-f424-e053-dadaa90a57ceDermaWash S2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42771-0036-1DermaWash S21 g in 1 BOTTLE, PLASTICSOAP14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42771-0036DERMAWASH S2 (SULFUR SOAP) SOAP [KAVI SKIN SOLUTIONS, INC.]4Legacy NDC, 1 package rows20201021_5313266e-a04d-7118-e054-00144ff88e88.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
42771-003642771-0036-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b221e710-f634-6af0-e053-2995a90a59695313266e-a04d-7118-e054-00144ff88e882020-10-20WarningsExact identifier
spl id: b221e710-f634-6af0-e053-2995a90a5969
spl set id: 5313266e-a04d-7118-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.